文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

代谢不健康的正常体重个体和代谢健康的肥胖个体患糖尿病和心血管疾病的风险。

Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals.

作者信息

Aung KoKo, Lorenzo Carlos, Hinojosa Marco A, Haffner Steven M

机构信息

Department of Medicine, University of Texas Health Science Center, San Antonio, Texas 78229.

出版信息

J Clin Endocrinol Metab. 2014 Feb;99(2):462-8. doi: 10.1210/jc.2013-2832. Epub 2013 Nov 20.


DOI:10.1210/jc.2013-2832
PMID:24257907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3913817/
Abstract

CONTEXT: The risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (DM) associated with obesity appears to be influenced by the coexistence of other metabolic abnormalities. OBJECTIVE: We examined the risk of developing CVD and DM in metabolically healthy obese (MHO) and metabolically unhealthy normal weight (MUH-NW) individuals. DESIGN AND SETTING: We analyzed prospective data of the San Antonio Heart Study, a population-based study among Mexican Americans and non-Hispanic whites (median follow-up, 7.4 y). PARTICIPANTS: Incident DM and CVD were assessed in 2814 and 3700 participants aged 25 to 64 years, respectively. MAIN MEASURES: MHO was defined as obesity (body mass index ≥ 30 kg/m(2)) with no more than one metabolic abnormality, and MUH-NW was defined as body mass index <25 kg/m(2) with two or more abnormalities. RESULTS: In logistic regression models, BMI was associated with incident DM after controlling for demographics, family history of DM, and fasting glucose (odds ratio × 1 SD, 1.7 [95% CI, 1.5-2.0]). Both MUH-NW and MHO individuals had an increased DM risk (2.5 [1.1-5.6] and 3.9 [2.0-7.4], respectively). Similarly, BMI was related to incident CVD after adjusting for demographics and Framingham risk score (1.3 [1.1-1.6]). Incident CVD was also increased in MUH-NW and MHO individuals (2.9 [1.3-6.4] and 3.9 [1.9-7.8], respectively). Results were consistent across gender and ethnic categories. CONCLUSION: The risk of developing DM and CVD is increased in MUH-NW and MHO individuals. Screening for obesity and other metabolic abnormalities should be routinely performed in clinical practice to institute appropriate preventive measures.

摘要

背景:与肥胖相关的心血管疾病(CVD)和2型糖尿病(DM)风险似乎受其他代谢异常共存的影响。 目的:我们研究了代谢健康的肥胖(MHO)和代谢不健康的正常体重(MUH-NW)个体发生CVD和DM的风险。 设计与地点:我们分析了圣安东尼奥心脏研究的前瞻性数据,这是一项针对墨西哥裔美国人及非西班牙裔白人的人群研究(中位随访时间为7.4年)。 参与者:分别对2814名年龄在25至64岁的参与者评估了新发DM情况,对3700名参与者评估了新发CVD情况。 主要测量指标:MHO定义为肥胖(体重指数≥30kg/m²)且代谢异常不超过一项,MUH-NW定义为体重指数<25kg/m²且存在两项或更多异常。 结果:在逻辑回归模型中,在控制了人口统计学因素、DM家族史和空腹血糖后,BMI与新发DM相关(优势比×1个标准差为1.7 [95%可信区间,1.5 - 2.0])。MUH-NW和MHO个体发生DM的风险均增加(分别为2.5 [1.1 - 5.6]和3.9 [2.0 - 7.4])。同样,在调整了人口统计学因素和弗雷明汉风险评分后,BMI与新发CVD相关(1.3 [1.1 - 1.6])。MUH-NW和MHO个体发生新发CVD的情况也增加(分别为2.9 [1.3 - 6.4]和3.9 [1.9 - 7.8])。结果在性别和种族类别中均一致。 结论:MUH-NW和MHO个体发生DM和CVD的风险增加。临床实践中应常规筛查肥胖及其他代谢异常,以采取适当的预防措施。

相似文献

[1]
Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals.

J Clin Endocrinol Metab. 2014-2

[2]
Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: A cohort study.

PLoS Med. 2020-10-30

[3]
The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.

PLoS One. 2020-9-18

[4]
Incidence of diabetes according to metabolically healthy or unhealthy normal weight or overweight/obesity in postmenopausal women: the Women's Health Initiative.

Menopause. 2020-6

[5]
Association between the metabolically healthy obese phenotype and the risk of myocardial infarction: results from the Kailuan study.

Eur J Endocrinol. 2018-12-1

[6]
Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study.

Eur Heart J. 2015-3-1

[7]
Effect of body shape on the development of cardiovascular disease in individuals with metabolically healthy obesity.

Medicine (Baltimore). 2020-9-18

[8]
Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study.

Diabetes Care. 2013-3-14

[9]
Risk of the Development of Diabetes and Cardiovascular Disease in Metabolically Healthy Obese People: The Korean Genome and Epidemiology Study.

Medicine (Baltimore). 2016-4

[10]
Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study.

BMC Public Health. 2016-4-1

引用本文的文献

[1]
Differences in fat distribution between metabolically unhealthy people with normal weight versus obesity, NHANES 2011-2018.

BMJ Open Diabetes Res Care. 2025-5-28

[2]
Body Mass Index and Cardiovascular Risk Markers: A Large Population Analysis.

Nutrients. 2025-2-20

[3]
Identification of metabolism related biomarkers in obesity based on adipose bioinformatics and machine learning.

J Transl Med. 2024-10-31

[4]
The Definition and Prevalence of Obesity and Metabolic Syndrome: Correlative Clinical Evaluation Based on Phenotypes.

Adv Exp Med Biol. 2024

[5]
Ultra-Processed Food Intake and Increased Risk of Obesity: A Narrative Review.

Foods. 2024-8-21

[6]
Metabolically healthy obesity and risks of cardiovascular disease and all-cause mortality, a matched cohort study: the Shizuoka study.

Int J Obes (Lond). 2024-8

[7]
Metabolically Unhealthy Normal Weight: Prevalence and Associated Factors in an Adult Population from Northwest Colombia.

Diabetes Metab Syndr Obes. 2024-3-18

[8]
Fat as a Friend or Foe of the Bone.

Curr Osteoporos Rep. 2024-4

[9]
Gut microbiome signature of metabolically healthy obese individuals according to anthropometric, metabolic and inflammatory parameters.

Sci Rep. 2024-2-11

[10]
Effect of Plasma Fibrinogen Levels on the Risk of Stroke in Patients with Type 2 Diabetes: A Systematic Review.

TH Open. 2024-1-30

本文引用的文献

[1]
Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?

Diabetes Care. 2013-5-1

[2]
Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study.

J Clin Endocrinol Metab. 2013-4-4

[3]
Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study.

Diabetes Care. 2013-3-14

[4]
Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease.

Metabolism. 2013-2-4

[5]
Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans.

Clin Endocrinol (Oxf). 2013-5-11

[6]
The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness.

Eur Heart J. 2012-9-4

[7]
Are there still healthy obese patients?

Curr Opin Endocrinol Diabetes Obes. 2012-10

[8]
Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality.

J Clin Endocrinol Metab. 2012-4-16

[9]
Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan.

Asia Pac J Clin Nutr. 2012

[10]
Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue.

J Lipid Res. 2012-2-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索